Literature DB >> 26031366

MiR-20a Induces Cell Radioresistance by Activating the PTEN/PI3K/Akt Signaling Pathway in Hepatocellular Carcinoma.

Yuqin Zhang1, Lin Zheng2, Yi Ding1, Qi Li3, Rong Wang1, Tongxin Liu4, Quanquan Sun4, Hua Yang5, Shunli Peng1, Wei Wang6, Longhua Chen7.   

Abstract

PURPOSE: To investigate the role of miR-20a in hepatocellular carcinoma (HCC) cell radioresistance, which may reveal potential strategies to improve treatment. METHODS AND MATERIALS: The expression of miR-20a and PTEN were detected in HCC cell lines and paired primary tissues by quantitative real-time polymerase chain reaction. Cell radiation combined with colony formation assays was administrated to discover the effect of miR-20a on radiosensitivity. Bioinformatics prediction and luciferase assay were used to identify the target of miR-20a. The phosphatidylinositol 3-kinase inhibitor LY294002 was used to inhibit phosphorylation of Akt, to verify whether miR-20a affects HCC cell radioresistance through activating the PTEN/PI3K/Akt pathway.
RESULTS: MiR-20a levels were increased in HCC cell lines and tissues, whereas PTEN was inversely correlated with it. Overexpression of miR-20a in Bel-7402 and SMMC-7721 cells enhances their resistance to the effect of ionizing radiation, and the inhibition of miR-20a in HCCLM3 and QGY-7701 cells sensitizes them to it. PTEN was identified as a direct functional target of miR-20a for the induction of radioresistance. Overexpression of miR-20a activated the PTEN/PI3K/Akt signaling pathway. Additionally, the kinase inhibitor LY294002 could reverse the effect of miR-20a-induced radioresistance.
CONCLUSION: MiR-20a induces HCC cell radioresistance by activating the PTEN/PI3K/Akt pathway, which suggests that miR-20a/PTEN/PI3K/Akt might represent a target of investigation for developing effective therapeutic strategies against HCC.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26031366     DOI: 10.1016/j.ijrobp.2015.04.007

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  44 in total

1.  MicroRNA-20a contributes to cisplatin-resistance and migration of OVCAR3 ovarian cancer cell line.

Authors:  Yankun Liu; Sugui Han; Yuhui Li; Yan Liu; Di Zhang; Yufeng Li; Jinghua Zhang
Journal:  Oncol Lett       Date:  2017-06-08       Impact factor: 2.967

2.  Serum miR-20a is a promising biomarker for gastric cancer.

Authors:  Ruirui Yang; Yun Fu; Ying Zeng; Mengqin Xiang; Yufang Yin; Li Li; Haifan Xu; Jing Zhong; Xi Zeng
Journal:  Biomed Rep       Date:  2017-02-20

Review 3.  The role of autophagy in hepatic fibrosis.

Authors:  Mei Sun; Li Tan; Min Hu
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

4.  Effects of microRNA-20a on the proliferation, migration and apoptosis of multiple myeloma via the PTEN/PI3K/AKT signaling pathway.

Authors:  Yanxia Jiang; Hong Chang; Guoan Chen
Journal:  Oncol Lett       Date:  2018-04-23       Impact factor: 2.967

Review 5.  The Complex Landscape of PTEN mRNA Regulation.

Authors:  Erin Sellars; Martino Gabra; Leonardo Salmena
Journal:  Cold Spring Harb Perspect Med       Date:  2020-06-01       Impact factor: 5.159

6.  CD133 promotes gallbladder carcinoma cell migration through activating Akt phosphorylation.

Authors:  Chen Li; Cong Wang; Yang Xing; Jiaojiao Zhen; Zhilong Ai
Journal:  Oncotarget       Date:  2016-04-05

7.  Oncogenic role of microRNA‑20a in human uveal melanoma.

Authors:  Jinzi Zhou; Jian Jiang; Shuhong Wang; Xiaobo Xia
Journal:  Mol Med Rep       Date:  2016-06-23       Impact factor: 2.952

8.  HBV core promoter mutations and AKT upregulate S-phase kinase-associated protein 2 to promote postoperative hepatocellular carcinoma progression.

Authors:  Lubiao Chen; Lin Gu; Yurong Gu; Hongbo Wang; Meihai Deng; Zania Stamataki; Ye Htun Oo; Yuehua Huang
Journal:  Sci Rep       Date:  2016-10-25       Impact factor: 4.379

9.  MiR-20a-5p promotes radio-resistance by targeting NPAS2 in nasopharyngeal cancer cells.

Authors:  Fangfang Zhao; Youguang Pu; Liting Qian; Chunbao Zang; Zhenchao Tao; Jin Gao
Journal:  Oncotarget       Date:  2017-11-11

10.  Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.

Authors:  Xiong Lei; Yun-Feng Li; Guo-Dong Chen; Di-Peng Ou; Xiao-Xin Qiu; Chao-Hui Zuo; Lian-Yue Yang
Journal:  Oncotarget       Date:  2015-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.